Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Venous Thromboembolism 10Neoplasms 8Venous Thrombosis 7Pancreatic Neoplasms 5Thrombosis 4Pulmonary Embolism 4Thromboembolism 3Hemorrhage 3Small Cell Lung Carcinoma 2Sarcoma 2Ovarian Neoplasms 2Lymphoma 2Carcinoma, Non-Small-Cell Lung 2Venous Thormboembolism 1Urinary Bladder Neoplasms 1Thrombocytopenia 1Stroke 1Stomach Neoplasms 1Soft Tissue Neoplasms 1Multiple Myeloma 1Malignant Female Reproductive System Neoplasm 1Lymphoma, Large B-Cell, Diffuse 1Liver Neoplasms 1Leukemia 1Hemostatic Disorders 1Hematoma 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Fibrosis 1

Interventions

temsirolimus 1binimetinib 1Valproic Acid 1Trabectedin 1Specimen Handling 1Sirolimus 1Laser Therapy 1Immunoglobulin G 1Enoxaparin 1Disulfides 1Cetuximab 1Biopsy 1Bevacizumab 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Soft Tissue Neoplasms × Enoxaparin × Clear all
NCT01965002 2018-05-23

Feasibility of ExAblate MRI Guided High Intensity Focused Ultrasound Tx of Soft Tissue Tumors

Stanford University

Phase NA Terminated
5 enrolled 8 charts

Soft Tissue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡